| Mark Francis Obenrader, MD PHD | |
|
515 Pennsylvania Ave, 2nd Fl Suite A, Fort Washington, PA 19034-3314 | |
| (215) 540-8408 | |
| (215) 540-8418 |
| Full Name | Mark Francis Obenrader |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 44 Years |
| Location | 515 Pennsylvania Ave, Fort Washington, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083698229 | NPI | - | NPPES |
| 007057785 | Medicaid | PA | |
| 110115445 | Other | PA | RAILROAD MEDICARE |
| P00360693 | Other | PA | RAILROAD MEDICARE TPI |
| 12212 | Other | PA | BRAVO HEALTH |
| 445439 | Other | PA | HIGHMARK BLUE SHIELD |
| 3725226 | Other | PA | AETNA HMO |
| 3Y7167 | Other | PA | HEALTH NET |
| 4104719 | Other | PA | AETNA PPO |
| 30019076 | Other | PA | KEYSTONE MERCY HEALTH PL |
| 0047316000 | Other | PA | INDEPENDENCE BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD025847E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Southeastern Home Health Services | Bristol, PA | Home health agency |
| Mercy Home Health | Springfield, PA | Home health agency |
| Continuous Home Care Inc | Havertown, PA | Home health agency |
| Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
| Doylestown Hospital | Doylestown, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Temple Physicians Inc | 2062317233 | 127 |
News Archive
Alzheimer's disease (AD) represents the leading cause of dementia worldwide. Currently, challenges in making an early and definitive diagnosis of AD limit opportunities to intervene with disease-modifying therapies before substantial neurodegeneration occurs.
PDS Biotechnology Corporation announced today that they have entered into an exclusive worldwide licensing agreement with Merck KGaA, Darmstadt, Germany, for use of PDS Biotechnology's novel Versamune nanotechnology platform in two of Merck's investigational antigen-specific cancer immunotherapies currently in pre-clinical development.
Beatriz Apellaniz, PhD holder of the UPV/EHU-University of the Basque Country, has studied in her PhD thesis HIV regions that could be used to design a vaccine. The researcher has focussed her research on a specific region of the surface protein of the Human Immunodeficiency Virus (HIV), which is responsible for the Autoimmune Deficiency Syndrome (AIDS), one of the diseases with the greatest human morbidity and mortality.
The new Deeplex®-MycTB mycobacterial antibiotic resistance test1, developed by GenoScreen, has been used by an international research team in a molecular epidemiology study published in The Lancet Infectious Diseases.
Children with a devastating genetic disorder characterized by severe motor disability and developmental delay have experienced sometimes dramatic improvements in a gene therapy trial launched at UCSF Benioff Children's Hospitals.
› Verified 3 days ago
| Entity Name | Temple Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942444088 PECOS PAC ID: 2062317233 Enrollment ID: O20040310000054 |
News Archive
Alzheimer's disease (AD) represents the leading cause of dementia worldwide. Currently, challenges in making an early and definitive diagnosis of AD limit opportunities to intervene with disease-modifying therapies before substantial neurodegeneration occurs.
PDS Biotechnology Corporation announced today that they have entered into an exclusive worldwide licensing agreement with Merck KGaA, Darmstadt, Germany, for use of PDS Biotechnology's novel Versamune nanotechnology platform in two of Merck's investigational antigen-specific cancer immunotherapies currently in pre-clinical development.
Beatriz Apellaniz, PhD holder of the UPV/EHU-University of the Basque Country, has studied in her PhD thesis HIV regions that could be used to design a vaccine. The researcher has focussed her research on a specific region of the surface protein of the Human Immunodeficiency Virus (HIV), which is responsible for the Autoimmune Deficiency Syndrome (AIDS), one of the diseases with the greatest human morbidity and mortality.
The new Deeplex®-MycTB mycobacterial antibiotic resistance test1, developed by GenoScreen, has been used by an international research team in a molecular epidemiology study published in The Lancet Infectious Diseases.
Children with a devastating genetic disorder characterized by severe motor disability and developmental delay have experienced sometimes dramatic improvements in a gene therapy trial launched at UCSF Benioff Children's Hospitals.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mark Francis Obenrader, MD PHD Po Box 820933, Philadelphia, PA 19182-0933 Ph: (215) 540-8408 | Mark Francis Obenrader, MD PHD 515 Pennsylvania Ave, 2nd Fl Suite A, Fort Washington, PA 19034-3314 Ph: (215) 540-8408 |
News Archive
Alzheimer's disease (AD) represents the leading cause of dementia worldwide. Currently, challenges in making an early and definitive diagnosis of AD limit opportunities to intervene with disease-modifying therapies before substantial neurodegeneration occurs.
PDS Biotechnology Corporation announced today that they have entered into an exclusive worldwide licensing agreement with Merck KGaA, Darmstadt, Germany, for use of PDS Biotechnology's novel Versamune nanotechnology platform in two of Merck's investigational antigen-specific cancer immunotherapies currently in pre-clinical development.
Beatriz Apellaniz, PhD holder of the UPV/EHU-University of the Basque Country, has studied in her PhD thesis HIV regions that could be used to design a vaccine. The researcher has focussed her research on a specific region of the surface protein of the Human Immunodeficiency Virus (HIV), which is responsible for the Autoimmune Deficiency Syndrome (AIDS), one of the diseases with the greatest human morbidity and mortality.
The new Deeplex®-MycTB mycobacterial antibiotic resistance test1, developed by GenoScreen, has been used by an international research team in a molecular epidemiology study published in The Lancet Infectious Diseases.
Children with a devastating genetic disorder characterized by severe motor disability and developmental delay have experienced sometimes dramatic improvements in a gene therapy trial launched at UCSF Benioff Children's Hospitals.
› Verified 3 days ago
Dr. Jay Richard Rosan, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1244 Fort Washington Ave, Family Practice Of Upper Dublin, Fort Washington, PA 19034 Phone: 215-237-1800 Fax: 215-643-6488 | |
Daniel Mark Moscow, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1244 Fort Washington Ave Ste E2, Fort Washington, PA 19034 Phone: 215-646-1686 Fax: 215-628-4956 | |
Dr. Burton Clay Plaster, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 709 Pennsylvania Ave # 1707, Fort Washington, PA 19034 Phone: 215-646-2322 Fax: 215-646-6202 | |
Sam Camie Masarachia, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1244 Fort Washington Ave, Ste E2, Fort Washington, PA 19034 Phone: 215-646-1686 Fax: 215-628-4956 | |
Adam Theodore Turk, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1244 Fort Washington Ave, Ste E, Fort Washington, PA 19034 Phone: 215-646-1686 Fax: 215-628-4956 | |
Julia Sanger, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 515 Pennsylvania Ave Ste A, Fort Washington, PA 19034 Phone: 215-540-8408 Fax: 215-540-8418 |